Correlation Between China Development and Medigen Vaccine
Can any of the company-specific risk be diversified away by investing in both China Development and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Development and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Development Financial and Medigen Vaccine Biologics, you can compare the effects of market volatilities on China Development and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Development with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Development and Medigen Vaccine.
Diversification Opportunities for China Development and Medigen Vaccine
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between China and Medigen is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding China Development Financial and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and China Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Development Financial are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of China Development i.e., China Development and Medigen Vaccine go up and down completely randomly.
Pair Corralation between China Development and Medigen Vaccine
Assuming the 90 days trading horizon China Development Financial is expected to generate 0.58 times more return on investment than Medigen Vaccine. However, China Development Financial is 1.71 times less risky than Medigen Vaccine. It trades about 0.05 of its potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about -0.05 per unit of risk. If you would invest 1,295 in China Development Financial on September 2, 2024 and sell it today you would earn a total of 425.00 from holding China Development Financial or generate 32.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
China Development Financial vs. Medigen Vaccine Biologics
Performance |
| Timeline |
| China Development |
| Medigen Vaccine Biologics |
China Development and Medigen Vaccine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with China Development and Medigen Vaccine
The main advantage of trading using opposite China Development and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Development position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.| China Development vs. Cathay Financial Holding | China Development vs. Mega Financial Holding | China Development vs. CTBC Financial Holding | China Development vs. Fubon Financial Holding |
| Medigen Vaccine vs. TaiMed Biologics | Medigen Vaccine vs. Adimmune Corp | Medigen Vaccine vs. PharmaEngine |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |